Hutterer, Georg C <br/><br/>
BioScore (B7-H1, survivin, and Ki-67) does not predict cancer-specific mortality in surgically treated patients with renal cell carcinoma: An external validation study.  [electronic resource] 

 -  Urologic oncology  07 2019 
 - 510-518 p.  digital 
<br/><br/> Publication Type: Journal Article; Validation Study 
<br/><br/><label>ISSN: </label>1873-2496 
<br/><br/><label>Standard No.: </label>10.1016/j.urolonc.2019.04.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>B7-H1 Antigen--analysis<br/>Carcinoma, Renal Cell--mortality<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Kaplan-Meier Estimate<br/>Ki-67 Antigen--analysis<br/>Kidney--pathology<br/>Kidney Neoplasms--mortality<br/>Male<br/>Middle Aged<br/>Neoplasm Grading<br/>Neoplasm Staging<br/>Nephrectomy<br/>Predictive Value of Tests<br/>Prognosis<br/>Survivin--analysis<br/>Treatment Outcome